0001209191-17-000952.txt : 20170104
0001209191-17-000952.hdr.sgml : 20170104
20170104163540
ACCESSION NUMBER: 0001209191-17-000952
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20161230
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZIOPHARM ONCOLOGY INC
CENTRAL INDEX KEY: 0001107421
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841475642
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE FIRST AVENUE
STREET 2: PARRIS BUILDING 34, NAVY YARD PLAZA
CITY: BOSTON
STATE: MA
ZIP: 02129
BUSINESS PHONE: 646-214-0700
MAIL ADDRESS:
STREET 1: ONE FIRST AVENUE
STREET 2: PARRIS BUILDING 34, NAVY YARD PLAZA
CITY: BOSTON
STATE: MA
ZIP: 02129
FORMER COMPANY:
FORMER CONFORMED NAME: EASYWEB INC
DATE OF NAME CHANGE: 20010213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEISER MICHAEL
CENTRAL INDEX KEY: 0001221449
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33038
FILM NUMBER: 17506075
MAIL ADDRESS:
STREET 1: 130 EAST 75TH ST
STREET 2: APT 6B
CITY: NEW YORK
STATE: NY
ZIP: 10021
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-12-30
0
0001107421
ZIOPHARM ONCOLOGY INC
ZIOP
0001221449
WEISER MICHAEL
C/O ZIOPHARM ONCOLOGY, INC.,
ONE FIRST AVENUE, PARRIS BLDG 34
BOSTON
MA
02129
1
0
0
0
Common Stock
2016-12-30
4
A
0
17204
0.00
A
213001
D
Common Stock
2016-12-31
4
F
0
9331
5.35
D
203670
D
17,204 shares shall vest on 12/30/2017.
Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
/s/ Caesar J. Belbel, Attorney-In-Fact
2017-01-04
EX-24.4_692107
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these present, that the undersigned hereby makes, constitutes and
appoints Laurence J.N. Cooper, Caesar J. Belbel, Kevin G. Lafond and Marc Recht
as the undersigned's true and lawful attorney-in-fact, with full power and
authority as hereinafter described on behalf of and in the name, place and stead
of the undersigned to:
(1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including
any amendments thereto) with respect to the securities of ZIOPHARM Oncology,
Inc., a Delaware corporation (the "Company"), with the United States Securities
and Exchange Commission, any national securities exchanges and the Company, as
considered necessary or advisable under Section 16(a) of the Securities Exchange
Act of 1934 and the rules and regulations promulgated thereunder, as amended
from time to time (the "Exchange Act");
(2) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such release of
information; and
(3) perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.
The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in their discretion on information provided to such
attorney-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney will be in such form and will
contain such information and disclosure as such attorney-in-fact, in his or her
discretion, deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirement of the Exchange
Act, (ii) any liability of the undersigned for any failure to comply with such
requirements, or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including without limitation the reporting requirements under Section 16 of the
Exchange Act.
The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, hereby ratifying all that such attorney-in-fact of, for and on
behalf of the undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney.
This Power of Attorney shall remain in full force and effect until revoked by
the undersigned in a signed writing delivered to such attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 5th day of January, 2016
/s/Michael Weiser
Michael Weiser, M.D., Ph.D.